Corporate Dermatology Grows as Arlington Clinic Joins Epiphany Network

AUSTIN, TX – February 09, 2026 – A long-established Arlington dermatology practice has been brought into the fold of a rapidly expanding national network, highlighting a significant and accelerating trend in American healthcare: the consolidation of independent medical practices. Epiphany Dermatology, an Austin-based company, announced its partnership with Arlington Dermatology Clinic, PA, a move that expands its footprint in the competitive Dallas-Fort Worth market and underscores the powerful forces reshaping specialty medicine.

The partnership brings Dr. Mary Adams, a respected board-certified dermatologist who has owned and operated the clinic since 2003, into Epiphany's network of over 119 locations across 18 states. For patients and physicians in the DFW area, the deal is a local manifestation of a national movement driven by private equity investment and the pursuit of operational scale.

The Rising Tide of Healthcare Consolidation

The partnership is far more than a simple business transaction; it is emblematic of a seismic shift in the healthcare landscape. Epiphany Dermatology itself is a product of this trend. Initially backed by CI Capital Partners in 2016, the company underwent a period of explosive growth, completing 39 acquisitions and expanding from a handful of clinics to 67 locations in just a few years. In 2022, it was acquired by Leonard Green & Partners, L.P., another major private equity firm, to fuel its next phase of expansion.

This aggressive “buy and build” strategy is common in dermatology, a sector that has become a darling for investors. The market is attractive due to its consistent revenue growth, projected at a compound annual rate of 13.4% in 2023, and its resilience during economic downturns. Furthermore, the industry is highly fragmented, with no single entity controlling more than one percent of the market. This creates a ripe environment for consolidators like Epiphany to acquire smaller practices and create economies of scale.

By 2023, an estimated 10% to 15% of all private dermatology practices in the U.S. were backed by private equity. The appeal is driven by an aging population—with patients over 60 accounting for 40% of industry revenues—and rising awareness of skin cancer and other dermatological conditions. For the investment firms, combining practices under one corporate umbrella allows for centralized billing, marketing, IT, and human resources, which can significantly reduce overhead and increase profitability.

The Doctor's Dilemma: Autonomy vs. Support

For independent physicians like Dr. Mary Adams, the decision to join a larger network represents a critical career crossroad. Running a private practice in the modern healthcare environment involves far more than treating patients. Physicians are often saddled with mounting administrative burdens, from navigating complex insurance reimbursements and ensuring regulatory compliance to managing staff, marketing, and technology upgrades.

In the announcement, Dr. Adams pointed to the alignment of values as a key factor. “My staff and I are excited to join the Epiphany team,” she stated. “Epiphany’s mission and values dovetail with what we believe in – integrity and providing excellent medical dermatology care for our patients. We look forward to working with Epiphany to maintain the highest standards of quality patient care.”

The partnership provides Arlington Dermatology Clinic with access to Epiphany’s extensive back-office support system. This offloads the operational headaches, allowing physicians to redirect their focus to clinical duties. This support structure was highlighted by Epiphany's CEO, Gheorghe Pusta, who noted the importance of cultural alignment and a shared commitment to patient care.

This trade-off—exchanging some degree of autonomy for robust operational support and financial stability—is becoming increasingly common. For many doctors, it is a pragmatic solution to the challenges of remaining independent in an industry that increasingly favors scale.

What the Change Means for DFW Patients

For the thousands of patients served by Arlington Dermatology Clinic, the transition raises important questions about the future of their care. Epiphany and Dr. Adams have framed the partnership as a win for the community, promising to enhance access and maintain high standards.

“We are excited to welcome Dr. Adams and her staff to Epiphany,” said Gheorghe Pusta, CEO of Epiphany. “This is an exciting opportunity to expand our provider network and improve access to great dermatologic care in Dallas-Fort Worth.”

Theoretically, being part of a larger network can bring tangible benefits to patients. These may include access to a wider range of insurance plans, streamlined online scheduling systems, modernized facilities, and the introduction of new technologies or cosmetic services. The collaborative nature of the network also means that best practices and clinical expertise from specialists like Dr. Adams can be shared across all 119 locations, potentially raising the standard of care.

However, the broader trend of PE-backed healthcare consolidation is not without scrutiny. Some academic studies have suggested that prices for routine medical visits can be slightly higher at private equity-owned practices compared to their independent counterparts. While proponents argue that efficiencies and improved access justify the model, consumer advocates watch closely to ensure that the drive for profitability does not come at the expense of the patient-doctor relationship or affordability. Patients of the Arlington clinic will now be part of this evolving model, where local, personalized care is integrated into a vast, national corporate structure.